KL and hyperlipidemia: In model 2, the relationship between Klotho and hyperlipidemia remained robust (per SD increment OR: 0.91; 95% CI: 0.86–0.97), indicating that each SD increment in Klotho was associated with a 9% decreased risk of hyperlipidemia.